Allen Kaplan to Basophils
This is a "connection" page, showing publications Allen Kaplan has written about Basophils.
Connection Strength
4.216
-
Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Allergy Asthma Proc. 2018 May 01; 39(3):184-190.
Score: 0.587
-
Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
Score: 0.300
-
IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
Score: 0.211
-
TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
Score: 0.192
-
A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8.
Score: 0.189
-
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells. J Allergy Clin Immunol Pract. 2021 06; 9(6):2195-2208.
Score: 0.180
-
Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
Score: 0.158
-
An IgE-dependent histamine-releasing factor (HRF) identical to a previously described human protein (P23) Allergy. 1998 Jul; 53(7):631-2.
Score: 0.148
-
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria. Allergy. 2017 Apr; 72(4):519-533.
Score: 0.134
-
Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996 Jan-Feb; 17(1):5-11.
Score: 0.125
-
Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5.
Score: 0.121
-
Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol. 1995 Feb; 95(2):574-86.
Score: 0.117
-
Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501.
Score: 0.113
-
Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43.
Score: 0.103
-
RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42.
Score: 0.098
-
Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol. 1992 Mar; 89(3):666-72.
Score: 0.096
-
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
Score: 0.095
-
Cytokine stimulation of human basophil histamine release. Immunol Ser. 1992; 57:573-86.
Score: 0.095
-
IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol. 1991 Sep 15; 147(6):1920-4.
Score: 0.093
-
Release of elastase from purified human lung mast cells and basophils. Identification as a Hageman factor cleaving enzyme. Inflammation. 1989 Jun; 13(3):295-308.
Score: 0.079
-
Pathogenesis of chronic urticaria. Clin Exp Allergy. 2009 Jun; 39(6):777-87.
Score: 0.078
-
Recombinant human interleukin-1 beta causes histamine release from human basophils. J Allergy Clin Immunol. 1988 Aug; 82(2):218-23.
Score: 0.075
-
Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul; 82(1):17-20.
Score: 0.074
-
Basophil secretion in chronic urticaria: autoantibody-dependent or not? J Allergy Clin Immunol. 2007 Sep; 120(3):729-30.
Score: 0.069
-
Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61.
Score: 0.068
-
Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9.
Score: 0.060
-
Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21.
Score: 0.059
-
Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
Score: 0.059
-
Chemokines, chemokine receptors and allergy. Int Arch Allergy Immunol. 2001 Apr; 124(4):423-31.
Score: 0.045
-
Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6.
Score: 0.037
-
Chemokines and the late-phase reaction. Allergy. 1998; 53(45 Suppl):27-32.
Score: 0.036
-
Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
Score: 0.034
-
Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
Score: 0.033
-
Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996 Jan; 97(1 Pt 1):104-12.
Score: 0.031
-
Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16.
Score: 0.022
-
Histamine-releasing factors. Int Arch Allergy Appl Immunol. 1991; 94(1-4):148-53.
Score: 0.022
-
Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60.
Score: 0.022
-
Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21.
Score: 0.021
-
Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
Score: 0.019
-
Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92.
Score: 0.019
-
Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum. 1988 Aug; 31(8):1000-6.
Score: 0.019
-
Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
Score: 0.018
-
Mediators of inflammation: an overview. Methods Enzymol. 1988; 163:3-23.
Score: 0.018
-
Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
Score: 0.015
-
Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
Score: 0.013
-
Contrast agents and anaphylactic-like reactions. J Allergy Clin Immunol. 1979 Apr; 63(4):225-7.
Score: 0.010
-
Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy. 1995 Sep; 25(9):890-5.
Score: 0.008